Literature DB >> 2478624

A distinct subset of human CD4+ cells with a limited alloreactive T cell receptor repertoire.

Y Morishita1, H Sao, J A Hansen, P J Martin.   

Abstract

We describe a subset of CD4+/CD3+ human T lymphocytes that demonstrated a remarkably limited TCR repertoire responding to alloantigen stimulation. These cells have been characterized previously by their granular morphology and expression of CD11b but not CD28. Whereas multiple CD28+/CD4+ alloproliferative cloned cell lines generated by culture at limiting dilution immediately after isolation from peripheral blood each had a unique TCR-beta gene rearrangement, 19 of 21 CD11b+/CD4+ clones showed identical TCR-beta, and gamma gene rearrangements. In conventional MLR, the CD11b+/CD4+ cells responded poorly after stimulation with some HLA-class II Ag, and staining with a TCR Id-specific antibody and DNA blot hybridization suggested that the responding CD11b+/CD4+ cells typically contained predominant clonal populations. Clones of CD11b+/CD4+ cells with different TCR gene rearrangements showed closely similar patterns of responses when stimulated by a panel of allogeneic PBMC, but the response pattern did not correspond to that of any known HLA-class II Ag. These findings indicate that CD11b+/CD4+ cells have a limited alloproliferative repertoire characterized by predominant recognition of a limited number of undefined determinants that appear to be expressed in association with multiple distinct HLA-class II Ag. Our results suggest that CD11b+/CD4+ cells are selected for clonal reactivity by processes distinct from those for CD28+/CD4+ cells.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2478624

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

1.  CD28 interaction with B7 costimulates primary allogeneic proliferative responses and cytotoxicity mediated by small, resting T lymphocytes.

Authors:  M Azuma; M Cayabyab; D Buck; J H Phillips; L L Lanier
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

2.  CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity.

Authors:  D Schmidt; J J Goronzy; C M Weyand
Journal:  J Clin Invest       Date:  1996-05-01       Impact factor: 14.808

3.  The repertoire of CD4+ CD28- T cells in rheumatoid arthritis.

Authors:  D Schmidt; P B Martens; C M Weyand; J J Goronzy
Journal:  Mol Med       Date:  1996-09       Impact factor: 6.354

Review 4.  Role of unusual CD4+ CD28- T cells in acute coronary syndrome.

Authors:  Wenjie Sun; Lihui Zheng; Lijuan Huang
Journal:  Mol Biol Rep       Date:  2011-06-22       Impact factor: 2.316

5.  Increased cytolytic T lymphocyte activity and decreased B7 responsiveness are associated with CD28 down-regulation on CD8+ T cells from HIV-infected subjects.

Authors:  J H Vingerhoets; G L Vanham; L L Kestens; G G Penne; R L Colebunders; M J Vandenbruaene; J Goeman; P L Gigase; M De Boer; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1995-06       Impact factor: 4.330

Review 6.  The story of CD4+ CD28- T cells revisited: solved or still ongoing?

Authors:  Kathrin Maly; Michael Schirmer
Journal:  J Immunol Res       Date:  2015-03-05       Impact factor: 4.818

7.  A pathway of costimulation that prevents anergy in CD28- T cells: B7-independent costimulation of CD1-restricted T cells.

Authors:  S M Behar; S A Porcelli; E M Beckman; M B Brenner
Journal:  J Exp Med       Date:  1995-12-01       Impact factor: 14.307

8.  Induction of alloantigen-specific hyporesponsiveness in human T lymphocytes by blocking interaction of CD28 with its natural ligand B7/BB1.

Authors:  P Tan; C Anasetti; J A Hansen; J Melrose; M Brunvand; J Bradshaw; J A Ledbetter; P S Linsley
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

9.  The expansion of CD4+CD28- T cells in patients with rheumatoid arthritis.

Authors:  Andrzej Pawlik; Lidia Ostanek; Iwona Brzosko; Marek Brzosko; Marek Masiuk; Boguslaw Machalinski; Barbara Gawronska-Szklarz
Journal:  Arthritis Res Ther       Date:  2003-05-14       Impact factor: 5.156

10.  Interleukin-7 and interleukin-15 drive CD4+CD28null T lymphocyte expansion and function in patients with acute coronary syndrome.

Authors:  Jessica Bullenkamp; Veronica Mengoni; Satdip Kaur; Ismita Chhetri; Paraskevi Dimou; Zoë M J Astroulakis; Juan Carlos Kaski; Ingrid E Dumitriu
Journal:  Cardiovasc Res       Date:  2021-07-07       Impact factor: 10.787

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.